Factors related to changes in CD4+ T-cell counts over time in patients living with HIV/AIDS: A multilevel analysis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Montarroyos, Ulisses Ramos ^a,b   Miranda Filho, Demócrito Barros ^b   César, Cibele Comini ^c   Souza, Wayner Vieira ^d   Lacerda, Heloisa Ramos ^a   Albuquerque, Maria De Fátima Pessoa Militão ^d   Aguiar, Mariana Freitas ^b   Ximenes, Ricardo Arraes De Alencar ^a,b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d s n Campus da Federal University of Pernambuco   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ILLICIT DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL ASSAY; CELL LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; NONHUMAN; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT MONITORING; PREDICTION; SMOKING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC;

EID: 84895534133     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084276     Document Type: Article

References (34)

1. Langford SE, Ananworanich J, Cooper DA (2007) Predictors of disease progression in HIV infection: a review. AIDS Res Ther 4:11.
2. Hoffman J, Griensven JV, McKella M (2010) Role of the CD4 count in HIV management. HIV Ther 4: 27-39.
3. Hoffman RM, Jamieson BD, Bosch RJ, Currier J, Kitchen MRC, et al. (2011) Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals. J Clin Immunol 31: 873-881.
4. Patroclo MAA, Medronho RA (2007) Evolution of CD4 + T-cell count among AIDS patients in socially unequal contexts. Cad Saude Publica 23: 1955-1963.
5. Lignani L, Bartolomeu D, Carneiro M (2001) Assessment of the compliance to antiretroviral drugs among HIV/AIDS patients. Rev Saude Publica 35: 495-501.
6. Kalichman SC, Ramachandran B, Catz S (1999) Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern med 14: 267-273. (Pubitemid 29226671)
7. Melchior R, Nemes MIB, Alencar TMD, Buchalla CM (2007) Challenges of treatment adherence by people living with HIV/AIDS in Brazil. Rev Saude Publica 41: 87-93.
8. Baum MK, Rafie C, Lai S, Sales S, Page JB, et al. (2010) Alcohol use accelerates HIV disease progression. AIDS research and human retroviruses AIDS Res Hum Retroviruses 26: 511-518.
9. Chu H, Gange SJ, Yamashita TE, Hoover DR, Chmiel JS, et al. (2005) Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model. Am J Epidemiol 162: 787-797. (Pubitemid 41437766)
10. Twisk JWR (2003) Applied Longitudinal Data Analysis for Epidemiology. Cambridge University Press. p. 301.
11. Willians AB (1999) Adherence to highly active antiretroviral therapy. Nurs Clin North Am 34: 113-129.
12. Diez-Roux AV (2000) Multilevel analysis in public health research. Annu Rev Public Health 21: 171-192.
13. Robbins GK, Daniels B, Zheng H, Chueh H, Meigs LB, et al. (2008) Predictors of Antiretroviral Treatment Failure in a Urban HIV Clinic. J. Acquir immune Defic Syndr 44: 30-37.
14. Nies-Kraske E, Schacker TW, Condoluci D, Orenstein J, Brenchley J, et al. (2009) Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. J infect Dis 199: 1648-1656.
15. Florence E, Lundgren J, Dreezen C, Fisher M, Kirk O, et al. (2003) Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV med 4: 255-262. (Pubitemid 36949882)
16. Ledergerber B, Lundgren JD, Walker AS, Sabin C, Justice M, et al. (2004) Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet Pub 364: 51-62.
17. Crothers K, Griffith TA, McGinnis KA, Rodrigues-Barradas MC, Leaf DA, et al. (2005) The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 20: 1142-1145. (Pubitemid 43110266)
18. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, et al. (2006) Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Epidemiol Public Health 96: 1060-1065. (Pubitemid 43825275)
19. Royce RA, Winkelstein W (1990) HIV infection, cigarette smoking and CD4+ T-lymphocyte counts. AIDS 4: 327-334.
20. Burns DN, Hillman D, Neaton JD, Sherer R, Mitchell T, et al. (1996) Cigarette Smoking, Bacterial Pneumonia, and Other Clinical Outcomes in HIV-1 Infection. J Acquir Immune Defic Syndr Hum Retrovirol 13: 374-383. (Pubitemid 26404532)
21. Craib KJ, Schechter MT, Montaner JS, Le TN, Sestak P, et al. (1992) The effect of cigarette smoking on lymphocyte subsets and progression to AIDS in a cohort of homosexual men. Clinical and investigative medicine. Clin Invest Med 15: 301-308.
22. Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, et al. (1996) The association between cigarette smoking and selected HIV-related medical conditions. AIDS 10:1121-1126. (Pubitemid 26283350)
23. Webb MS, Vanable PA, Carey MP, Blair DC (2007) Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med 30: 371-383. (Pubitemid 47206603)
24. Chao C, Jacobson LP, Tashkin D, Mertinez-Maza O, Roth MD, et al. (2008) Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men. Drug Alcohol Depend 94: 165-171.
25. Shuter J, Bernstein SL (2008) Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res 10: 731-736. (Pubitemid 351566558)
26. Baum MK, Rafie C, Lai S, Sales S, Page B, et al. (2009) Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J. Acquir immune Defic Syndr 50: 93-99.
27. Cook JA, Burke-Miller JK, Cohen MH, Cook RL, Vlahov D, et al. (2008) Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS 22: 1355-1363.
28. Webber MP, Schoenbaum EE, Gourevitch MN, Buono D, Klein RS (1999) A prospective study of HIV disease progression in female and male drug users. AIDS 13: 257-262. (Pubitemid 29050414)
29. Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, et al. (2003) Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med 139: 258-266.
30. Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, et al. (2002) A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 16:2175-2182. (Pubitemid 35387272)
31. Zolnierek KBH, Dimatteo MR (2009) Physician communication and patient adherence to treatment: a meta-analysis. Medical care 47: 826-834.
32. Barfod TS, Hecht FM, Rubow C, Gerstoft J (2006) Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory. BMC Health Serv Res 6:154.
33. Herrera C, Campero L, Caballero M, Kendall T (2008) Relationship between physicians and HIV patients: influence on adherence and quality of life. Rev Saude Publica 42: 249-255.
34. Garcia R, Lima MG, Gorender M, Badaró R (2005) The importance of the doctor-patient relationship in adherence to HIV/AIDS treatment: a case report. Braz J Infect Dis 9:251-256. (Pubitemid 41657677)